Net income available to common shareholders in second quarter 2024 was $259 million, or $2.64 per diluted share Adjusted diluted earnings per share 1 was $2.31 in second quarter 2024 Consolidated Adjusted EBITDA 1 in second quarter 2024 of $945 million increased 12.1% over second quarter 2023 Second quarter 2024 Ambulatory Care Adjusted EBITDA of $447 million increased 20.8% over second quarter 2023 Board of Directors has... Read More